Under the Radar: 3 Boring Small Caps That Could Return 10x
Bioventus Inc BVS
$13.17
▼ -0.08%
($-0.01)
📈 Near 52W High
📅 Earnings This Week
Open
$13.15
Prev Close
$13.18
Day Range
$12.43 – $13.25
52W Range
$5.81 – $13.55
Market Cap
$1.10B
P/E (TTM)
38.63
Beta
0.69
EPS (TTM)
$0.41
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-02-11 |
| Shares Out. | 67,750,000 |
| Website | bioventus.com/ ↗ |
| Phone | 13026587581 |
| Employees | 940 |
| Revenue | $132.1M |
| Gross Profit | $90.8M |
| Net Income | $3.9M |
| Free Cash Flow | $100.6M |
| Total Assets | $650.5M |
| Total Liabilities | $416.3M |
| Equity | $234.3M |
About Bioventus Inc
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
Bioventus Inc is a publicly traded company under the ticker symbol BVS on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-07-01)